Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Evaluation of ultrasonic transient elastography (fibroscan) in Egyptian chronic HCV patients

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Role of transient elastography (fibroscan) in assessment of liver fibrosis in chronic hepatitis C patients

Evaluation of post interferon therapy changes in chronic HCV patients : Clinical, Doppler ultrasonography and histopathological study

Assessment of fibrosis biomarkers alone and incombination with tissue harmonic imaging versushistopathological fibrosis scoring in patients withchronic HCV infection and /or NASH

Correlation of ultrasonographic findings with histopathological diagnosis in HCV related chronic liver diseases

Fibroindex, a simple noninvasive test forprediction of fibrosis in patients withchronic hepatitis C virus infection

Pattern of steatosis and histopathological changes in patients with chronic HCV